The development of in vivo imaging protocols to reliably track transplanted cells or to report on gene expression is critical for treatment monitoring in (pre)clinical cell and gene therapy protocols. Therefore, we evaluated the potential of lentiviral vectors (LVs) and adeno-associated viral vectors (AAVs) to express the magnetic resonance imaging (MRI) reporter gene ferritin in the rodent brain. First, we compared the induction of background MRI contrast for both vector systems in immune-deficient and immune-competent mice. LV injection resulted in hypointense (that is, dark) changes of T 2 /T 2 * (spin-spin relaxation time)-weighted MRI contrast at the injection site, which can be partially explained by an inflammatory response against the vector injection. In contrast to LVs, AAV injection resulted in reduced background contrast. Moreover, AAV-mediated ferritin overexpression resulted in significantly enhanced contrast to background on T 2 *-weighted MRI. Although sensitivity associated with the ferritin reporter remains modest, AAVs seem to be the most promising vector system for in vivo MRI reporter gene imaging. Gene Therapy (2011) 
INTRODUCTION
The development of non-invasive imaging methods that can reliably report on therapeutic cell transplantation and/or gene expression is a critical step in the establishment of gene therapy protocols, both for clinical and for research applications. Several molecular imaging modalities are available that enable non-invasive and repeated imaging of gene expression in targeted cells in living organisms, thereby reducing the number of laboratory animals and reducing the inter-animal variability at the preclinical level. Among these are radionuclide imaging techniques such as single-photon emission computed tomography (SPECT) and positron emission tomography (PET), optical imaging methods including fluorescence imaging and bioluminescence imaging (BLI), magnetic resonance imaging (MRI) and spectroscopy, ultrasound and X-ray-based methods (for a review, see the studies by Massoud and Gambhir 1 and Deroose et al. 2 ). Apart from optical imaging methods, molecular imaging technologies using these imaging modalities have the advantage of being translatable to a clinical setting.
When comparing imaging modalities, BLI, PET and SPECT provide high sensitivity but low resolution, whereas MRI can reach near-cellular resolution, [3] [4] [5] [6] which makes MRI ideally suited to provide information on the location and migration of targeted cells in vivo.
Cellular contrast for MRI typically requires (pre)labeling of cells of interest with MRI contrast agents to discriminate them from the surrounding tissue (for more background reading about contrast generation for MRI, we refer to the studies by Vande Velde et al., 3 Heyn et al., 4 Shapiro et al., 5 Himmelreich and Dresselaers 6 and Bulte and Kraitchman 7 ). The resulting image does not reflect cell viability and quantity, nor can it report on cellular and molecular function. 3, 6, 7 On the contrary, gene-based endogenous production/accumulation of MRI contrast for cell tracking has many advantages over prelabeling with contrast agents in vitro. Importantly, there is no essential dependence on substrate administration. Genetic reporters can be incorporated into gene delivery systems like viral vectors or into expression cassettes when generating transgenic animals. Their expressions can be coupled to the expression of a (therapeutic) transgene of interest or combined with other reporter genes for multimodality imaging, which is often required in gene therapeutic applications. Moreover, incorporation into an inducible expression system is possible, which holds the potential for dynamic sensing of gene expression. In addition, dilution of contrast agents and subsequent signal loss upon cell division would not be a concern. Although the use of reporter genes for BLI (for example, luciferases), for fluorescence imaging (for example, enhanced green fluorescent protein (eGFP)) and for PET (for example, HSV1-tk) is common practice (for an overview, see the studies by Deroose et al. 2 and Waerzeggers et al. 8 ), efforts are made to develop and validate gene-based contrast methods for MRI. [9] [10] [11] [12] [13] The genes proposed as 'pure' genetic MRI reporters, meaning that contrast generation is independent of (co-) substrate administration, are typically genes encoding proteins that sequester endogenous (super)paramagnetic ions. Several research groups have used different genetic systems to increase the cellular contrast for MRI with varying success. 3, 14 The concept of using ferritin as an MRI reporter is based on its natural iron-sequestering function. Ferritin is a ubiquitously expressed metalloprotein, assembled out of 24 light and heavy subunits. It accumulates endogenous Fe(II) from the intracellular labile iron pool of the organism and stores it as ferrihydrite. This elicits a high superparamagnetism that significantly affects MR relaxation times (for example, spin-spin relaxation time (T 2 *)). The most sensitive MRI method for the detection of iron-accumulating cells is based on hypointense (that is, dark) contrast in so-called T 2 *-weighted MR images. 3, 6, 7 These images are based on modulations of T 2 * relaxation times. The iron stored as Fe(III) in ferritin does not take part in the Fenton reaction, and is therefore not expected to be toxic. 15 The first use of ferritin to visualize cells with MRI was carried out by stably transfecting C6 glioma cells with the murine ferritin heavy subunit (FerrH) and eGFP under tetracycline control. 9 A significant difference in T 2 * values was also found between the tumor formed by mouse ES cells, which were transduced with a lentiviral vector (LV) encoding for FerrH and the wild-type tumor. 16 Transgenic mice expressing FerrH in a tissue-specific and tetracycline-dependent manner, show tissuedependent changes in T 2 values that could be detected by MRI. 17 The feasibility of using an iron-sequestering protein as an MRI reporter by in situ viral vector-mediated delivery was demonstrated by Genove et al. 10 An adenoviral vector was used to transiently overexpress human FerrH in the mouse brain, which resulted in significant hypointense (that is, dark) MRI contrast at the site of vector injection. 10 However, the sensitivity of the reported systems is limited. Moreover, for many applications (including stem cell studies and gene therapy protocols), stable gene transfer is required, while adenoviral vectors are non-integrating vectors that are still frequently associated with a significant inflammatory response.
LVs derived from HIV-1 (human immunodeficiency virus type 1) and adeno-associated viral vectors (AAVs) are the preferred viral vector systems for reporter gene delivery when aiming for stable, long-term labeling and in vivo visualization of targeted cells. 18, 19 LVs provide one of the most efficient methods for stable gene delivery in vivo. As LVs efficiently transduce non-dividing post-mitotic and quiescent cells, they are ideal vehicles for gene transfer into the central nervous system (CNS), including endogenous neural stem and progenitor cells. [20] [21] [22] LVs are integrating vectors that stably mark cells and their progeny. After transduction of cells with LVs, the labeling will expand stoichiometrically as cells proliferate, providing a non-invasive means to follow cell progeny longitudinally.
Recombinant AAVs (rAAVs) are also strong candidates for applications in different target tissues, including the CNS. 23, 24 As rAAVs can target neurons in the nervous system depending on the (hybrid) serotype, these vectors are valuable tools for CNS disease modeling, for the treatment of neurological disorders or for the study of nervous system biology. 24, 25 Gene expression directed by rAAV transgene cassettes occurs mainly without integration into the host genome. However, gene expression will persist for several months to years in slowly dividing or non-dividing cells, as is the case for most adult brain cells. 26 In vivo visualization of cells using LV-delivered MRI reporter genes for marking cell populations by expression of ferritin will allow stable cell labeling that is not lost upon cell division as compared with particle-based labeling methods. 3 The potential limitations of viral vector-based systems for visualization by MRI are often insufficiently addressed. One such potential limitation is the generation of unspecific contrast by the vector itself and subsequent immune reactions by the host. In this study, we compared the potential of LVs and AAVs to stably overexpress the MRI reporter gene ferritin in vivo. We compared the induction of background contrast for both vector systems versus their ability to allow sensitive detection of MRI contrast based on ferritin overexpression in the mouse brain.
RESULTS

LVs encoding ferritin induce iron accumulation and MR contrast in cultured cells
As FerrH is responsible for iron incorporation and sufficient for contrast generation, 9 we used the human FerrH gene cDNA without the iron-responsive element to ensure constitutive expression. The FerrH-cDNA was cloned in a lentiviral transfer plasmid resulting in pCHMWS-FerrH-T2A-fLuc, which encodes for both FerrH and firefly luciferase (fLuc) separated by the T2A peptide sequence. 27 We used pCHMWS-eGFP-T2A-fLuc as a control plasmid (Figure 1a ). 293T cells were transduced with LV-eGFP-T2A-fLuc or LV-FerrH-T2A-fLuc (normalized for p24 antigen) at two dilutions. Transduced cells were passaged at least four times to avoid pseudo-transduction. Confirmation of stable transgene expression was obtained by measuring luciferase reporter gene activity by a bioluminescence assay on extracts obtained from transduced cells harvested at regular time points up to 4 weeks after transduction (data not shown). Western blot analysis confirmed the correct size of all proteins expressed (Figure 1b) . In LV-FerrH-T2A-fLuc-transduced cells, a dilution-dependent band corresponding to FerrH-T2A overexpression was detected that corresponded with the expected molecular weight (±21 kDa). Endogenous FerrH was undetectable in transduced and untransduced cells. eGFP-T2A was only detected in LV-eGFP-T2A-fLuc-transduced control cells. The bicistronic FerrH-T2A-fLuc and eGFP-T2A-fLuc constructs are efficiently cleaved, although a faint band corresponding to the fusion proteins was detected after long exposure (Figure 1b) . The cleavage efficiency for the FerrH and eGFP constructs (FerrH-T2A/(FerrH-T2A+FerrH-T2A-fLuc) and eGFP-T2A/(eGFPT2A+eGFP-T2A-fLuc)) was 94 and 90%, respectively. FerrH overexpression was also confirmed by immunocytochemistry on LV-FerrH-T2A-fLuc-transduced 293T cells ( Figure 1c ) and SHSY5Y cells (data not shown).
The impact of FerrH overexpression on the intracellular iron content of the cells was evaluated by Prussian blue staining, inductively coupled plasma mass spectrometry and MRI. Upon incubation of cells in the Fe(III)-supplemented medium, positive Prussian blue staining was observed in FerrH-overexpressing cells but not in control LV-eGFP-T2A-fLuc-transduced cells (Figure 2a , upper panels). Under unsupplemented culture conditions, Prussian blue staining was negative in both cell lines (Figure 2a , lower panels). More sensitive detection and quantification of the intracellular iron content of these cells with inductively coupled plasma mass spectrometry demonstrated that cells have a higher iron loading when grown in the Fe(III)-supplemented cell culture medium than in an unsupplemented medium. When grown in the Fe(III)-supplemented medium, but also in the non-supplemented cell culture medium, FerrHoverexpressing cells accumulated significantly more iron than did control-transduced cells (Figure 2b ; P-values o0.05), showing that FerrH-overexpressing cells are capable of accumulating higher amounts of iron.
To verify whether the accumulation of iron in FerrH-overexpressing cells leads to a detectable change in MR contrast, high-resolution T 2 *-weighted three-dimensional (3D) MR images, T 2 and T 2 * maps of wild-type cells, LV-FerrH-T2A-fLuc-and LV-eGFP-T2A-fLuc-transduced 293T cells were acquired. Significant differences in contrast ( Figure 3a ) and relaxivity (Figures 3b-e ) between cells cultured with or without Fe(III) supplementation in the medium were observed. T 2 maps, which provide quantitative information on contrast changes, did not reveal significant differences between unsupplemented eGFPand FerrH-expressing cells (T 2 value changes relative to wild-type cells (set to 1) of 0.96 ± 0.03 and 0.93 ± 0.02, respectively, Figures 3b and c) . When cultured in the Fe(III)-supplemented medium, FerrH-transduced cells showed a significantly reduced T 2 value than did eGFPtransduced control cells (0.46±0.01 versus 0.57±0.02, Po0.05) (Figures 3b and c) . T 2 * maps, which are more sensitive to ironinduced magnetic susceptibility changes, revealed small but significant differences between the T 2 * values for unsupplemented eGFP-and FerrH-transduced cells (relative T 2 * values were 0.94 ± 0.02 and 0.89 ± 0.02, respectively, Po0.05) (Figures 3d and e) . Upon Fe(III) supplementation, T 2 * measurements clearly show a lower T 2 * for FerrH-expressing cells than for eGFP-transduced control cells (0.47±0.02 versus 0.60±0.02, respectively, Po0.05) (Figures 3d  and e) .
Control LV injection in the rodent brain induces background contrast in MRI To validate FerrH-overexpressing LVs for MRI reporter gene expression in the mouse brain, MRI contrast (T 2 /T 2 *-weighted) after stereotactic injection of a control LV was evaluated. LVs encoding for eGFP (LV-eGFP) were stereotactically injected into the right striatum of C57BL6 mice and compared with a phosphate-buffered saline (PBS) sham injection into the contralateral hemisphere. To rule out differences between individual viral vector batches, we used two LV batches (LV-eGFP (1) and LV-eGFP (2), n¼5 per batch). Highresolution 3D T 2 *-weighted MRI, T 2 and T 2 * maps were acquired before injection and at different time points from 24 h up to Figure S2) . However, these differences did not reach significance most likely because of the lower resolution and sensitivity of the T 2 /T 2 * maps. After the last time point, mice were perfused, ex vivo MR images on isolated brains were acquired and the brains were subsequently processed for histological analysis. PBS (1) LV-eGFP (1) PBS (2) LV-eGFP (2) contrast volume (mm Figure S2 ) did not show significant differences between the hemispheres with LV and PBS injections. On the other hand, DAB (diaminobenzidine)-enhanced Prussian blue staining revealed the presence of iron along and near the LV injection tract, which corresponded to the hypointense contrast seen on the high-resolution 3D T 2 * MR images. This hypointense contrast also coincided with the presence of infiltrated microglia/macrophages along the injection tract (Figures 4a and e) .
To exclude potential contributions of iron-containing components of the cell culture medium (such as transferrin) in the LV preparation to the background contrast on MR images, we also injected the concentrated cell culture medium in mice (n¼4). The contrast intensity and volume were comparable with the PBS injection at all time points p.i., indicating that contributions from the concentrated medium in a LV preparation to the MRI contrast are negligible (data not shown).
The MRI background contrast induced by a control LV is reduced in immune-deficient mice As ferritin is a marker for reactive microglia, 28 infiltration of these phagocytic cells at the injection tract might contribute to the background contrast seen on MRI after LV injection as also indicated by histology. To test this hypothesis, a control LV (LV-eGFP-T2A-fLuc) was injected into the right striatum of NOD-SCID immune-deficient mice. A PBS injection in the contralateral hemisphere was performed as control (n¼5). We performed BLI to non-invasively assess efficient transduction in vivo (data not shown). The contrast volume on 3D T 2 *-weighted in vivo MR images performed at 1 day, 1 week, 1 and 3.5 months p.i., was significantly reduced compared with immunecompetent C57BL6 mice, but was still considerably higher than the contrast volume generated by the injection of PBS (Figures 5a and b) . Immunohistochemical staining for CD11b showed reduced numbers of infiltrated microglia/macrophages along the injection tract, suggesting that an immune and/or inflammatory reaction of those iron-accumulating cells contributed to the background contrast observed with T 2 *-weighted in vivo MRI in immune-competent mice after LV injection (Figure 5c ). The hypointense MRI contrast induced by FerrH-LV after injection in the mouse brain is not significantly different from the contrast of a control LV Comparison of the hypointense contrast on 3D T 2 *-weighted in vivo MRI generated p.i. of a FerrH-encoding LV (LV-FerrH-T2A-fLuc) with a control LV injection (LV-eGFP-T2A-fLuc) in the immunecompetent mouse brain did not show clear differences in contrast compared with the background at 2 weeks p.i. (n¼3, data not shown). Owing to the reduced background contrast in immune-deficient mice, FerrH-encoding LVs were tested in immune-deficient mice by injection of LV-FerrH-T2A-fLuc and LV-eGFP-T2A-fLuc into the right and left striata, respectively, of NOD-SCID mice (n¼5). We confirmed efficient transduction in vivo by performing non-invasive BLI (data not shown). The 3D T 2 *-weighted MR images and T 2 /T 2 * maps were acquired before and at 1 day, 1 week and 1 month p.i. A trend towards a higher hypointense contrast volume for the FerrH-expressing vector was observed on the T 2 *-weighted in vivo MR images compared with the control vector (Figure 5d ), but the differences were non-significant (Figures 5e and f) . Prussian blue staining revealed the presence of low amounts of ferric iron along and close to the injection tract of both the FerrH-encoding and the control LV (Figure 5g) . Very low numbers of microglia/macrophages were visualized with immunohistochemistry, indicating that the contribution of these cells to the observed hypointense contrast is minimal (Figure 5h ). Taken together, even in immune-deficient mice wherein the background contrast is considerably lower than in immune-competent mice, MRI contrast was similar for LV-mediated FerrH MRI reporter gene expression compared with the contrast generated by a control vector injection.
AAVs induce lower MRI background contrast in the mouse brain than do LVs The AAVs are next to LVs widely used for stable gene delivery into the rodent brain. As AAV particles are more stable than LVs, more extensive purification procedures are possible, which might be beneficial for the detection of MRI reporter gene activity above background contrast levels. Moreover, AAVs generally reach higher vector titers than do LVs and therefore higher transgene expression levels. To address the MRI background contrast p.i. of an AAV control vector in the brain of immune-competent mice, AAV-eGFP-T2A-fLuc and PBS were injected into the right and left striata of C57BL6 mice (n¼5). In vivo transgene expression was confirmed non-invasively by measuring fLuc reporter gene expression using BLI (Figures 6a and b) . We acquired MRI scans before and at 1 day, 1 week, 1 month and 4 months p.i. The contrast volume of AAV injection was comparable with the contrast volume of a PBS sham injection at all time points (Figures 6c-e) . Immunohistochemistry revealed a large eGFP-transduced area that, similar to the LV injection, exceeded the area affecting the MRI contrast (Figure 6f ). Immunohistochemical staining for CD11b showed minor infiltration of microglia/macrophages into the injection tract and a diffuse presence of microglia/macrophages AAV-mediated FerrH expression induces specific MRI contrast in the mouse brain Taking into account the high titers and low background contrast levels after AAV injection in the mouse brain, high titer-purified AAV-FerrH-T2A-fLuc and AAV-eGFP-T2A-fLuc were injected into the right and left striata of C57BL6 mice (n¼5). Efficient transgene expression was confirmed by in vivo BLI (data not shown). We acquired MRI scans before and at 1 day, 1 week and 1 month p.i. On 3D T 2 *-weighted in vivo MR images, the FerrH-expressing AAV injection resulted in significantly higher, readily observable hypointense contrast levels at all time points p.i. when compared with the lower background contrast levels for AAV-control vector injection (Figures 7a-c) . The volume of hypointense MRI contrast for both the AAV-FerrH-T2A-fLuc and the AAV-eGFP-T2A-fLuc vector injections increased from day 1 to 1 week p.i. (Figure 7c ), which most likely reflects the kinetics of AAV uncoating and transgene expression. The increase in contrast volume after day 1 was 11-fold higher at the site of FerrH overexpression than for the control, which is in agreement with specific contrast due to MRI reporter gene activity. A large area of transgene expression was confirmed by immunohistochemical staining for eGFP (Figure 7d ). DAB-enhanced Prussian blue staining revealed a pronounced presence of iron at the FerrH injection tract, whereas only traces of iron could be detected at the control injection site, which is in agreement with the MRI contrast ( Figure 7e ) and the T 2 /T 2 * values for the areas surrounding, but not including, the hypointense volume determined from the high-resolution 3D T 2 * MRI (Supplementary Figure S2) . The accumulation of iron did not coincide with the presence of microglia/macrophages as very few microglia had infiltrated into the area near the injection tracts as confirmed by immunohistochemistry (Figure 7f ). We performed this experiment with two different AAV batches and obtained the best results in terms of lowest background contrast and highest specific FerrH contrast with the highest-titer-purified vector batch.
DISCUSSION
In this study, we have evaluated in depth the potential of ferritin as an MRI reporter in the mouse brain with two different viral vector systems. We compared LVs and AAVs as these are the most promising viral vectors for applications in the CNS. LVs and AAVs were evaluated with regard to their background contrast on MRI and their potential to overexpress ferritin as an MRI reporter gene. We aimed to use maximal vector titers that can generally be obtained for the two vector systems, using optimized production protocols. 29, 30 We first tested bicistronic LVs for combined MRI and BLI reporter gene expressions. This enabled us to validate MRI reporter gene expression in unselected, stably transduced cells and to measure gene expression in the mouse brain based on the bioluminescence signal. In vitro experiments showed that FerrH-overexpressing cells accumulate more iron than do control cells, which significantly affected MR relaxation rates in cells. This was shown previously using cells selected for the highest reporter expression levels before implantation. 9, 16 FerrH-expressing cells without a priori selection of highly transduced cells were distinguishablealthough less sensitively-from control cells if cultured in an iron-supplemented medium. Preselection of cells with the highest 
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FerrH expression was avoided in our study as to mimic more closely in situ transduction of the brain.
Instead of a mere visual examination of the MR images and subjective appreciation of the viral vector-induced contrast, we aimed to objectively quantify the contrast from T 2 /T 2 * MRI data. A reliable fitting of T 2 /T 2 * values was not possible near the injection tract because of rapid signal quenching. Owing to the low sensitivity and resolution of T 2 /T 2 * maps, contrast quantification was also performed by analyzing the hypointense contrast volume at the injection site in the highresolution 3D T 2 *-weighted MRI. Manual delineation of volumes (volume of interest, VOI) in the MR images at each time point is tedious and error prone. Moreover, assessment of temporal changes is complicated by inter-scan variability and differences in image slice positioning in the case of T 2 /T 2 * maps. Hence, we developed an image analysis pipeline to objectively compare, quantify and statistically analyze differences or changes in contrast over time and between groups. Such comparison is much facilitated by the automated spatial alignment and intensity normalization implemented in our image analysis pipeline, such that the same VOI can be identified in all images and hypointense voxels can be detected and consistently quantified.
As any hypointense contrast evoked by MRI reporter gene expression should be significantly different from the background contrast caused by the injection of the vector, we investigated the background contrast induced by a viral vector injection in the mouse brain. Background contrast can result from bleedings or tissue damage resulting from the injection itself, from debris injected with the vector preparation or from an inflammatory response to the injection. After control LV injections in the mouse brain, we observed a hypointense background contrast, which was not caused by mechanical damage or bleeding due to the injection. A local accumulation of iron-accumulating microglia and macrophages was detected in and close to the needle track, which might be responsible for the contrast generation on MRI in close proximity to the site of injection. It has been shown before in a stroke model that macrophage infiltration can cause hypointense contrast on T 2 *-weighted MRI. 31 In addition, microglial activation is consistently associated with the accumulation of intrinsic iron by these cells. [32] [33] [34] When we injected LVs into immune-deficient mice, the background contrast and microglial/macrophage cell infiltration was considerably reduced, suggesting that a moderate immune/inflammatory response might at least partially explain the background contrast seen on MRI after LV-mediated transduction of the mouse brain. These findings imply that any hypointense contrast contributed by an MRI reporter gene after direct injection into a host has to be significantly stronger than the background contrast, challenging its sensitivity. This was further highlighted by the fact that no statistically significant difference was found between the injection of LV encoding FerrH in the brains of immune-deficient mice compared with LV encoding for eGFP. The contrast-to-background ratio might be improved by increasing ferritin overexpression levels, but as we were already using upscaled LV productions, 30 we decided to switch to the higher-titer AAVs.
We first tested AAVs with regard to their MRI background contrast after stereotactic injection in the mouse brain and found that the background contrast caused by high-titer-purified AAV injection in the brain was B50% lower than with LV. Our findings are in accordance with the results of several groups that have found that rAAV injections do not induce astrogliosis or infiltration of microglia into the brain [35] [36] [37] or to a very low extent. 38 The better performance of AAVs in terms of background contrast generation might be explained by the fact that AAV particles are not enveloped, and can therefore withstand more extensive concentration and purification procedures resulting in higher titer and purity. Owing to the higher expression levels combined with the reduced background contrast, AAV-mediated MRI reporter gene delivery to the rodent brain resulted in a better distinction between the contrast generated by the vector encoding for FerrH from a control vector injection (eGFP) and hence a better contrast to background.
Although a large part of the brain hemisphere was transduced by injection of LVs and even more by injection of AAVs, the MRI contrast remained localized to a narrow area around the injection site for vectors encoding for FerrH and for eGFP. In and around the injection tract, cells are transduced with the highest number of vector particles per cell and therefore have the highest expression levels. Although not quantifiable by immunohistochemistry, one can assume that cells transduced with the vector and expression levels will decrease rapidly with increasing distance from the injection site. Our results also confirm a relatively high threshold for in vivo detection of FerrH reporter gene activity by MRI. This is also demonstrated by the fact that most applications of ferritin as an imaging reporter gene focus on models with a sufficiently high concentration of cells with high expression levels. Therefore, considerable enhancement of the sensitivity will be required for most biological applications of ferritin as an MRI reporter gene. The relatively low sensitivity of ferritin can be explained by the fact that it is predominantly anti-ferromagnetic, causing a cancellation of most of the magnetic spin pairs. Only the presence of unpaired spins on the surface of the ferritin crystal core provides it with a net magnetic moment, 39 making the particle magnetic moment several orders of magnitude smaller than in superparamagnetic iron oxide particles. 14 In other words, ferritin is only partly superparamagnetic, and the native ferritin protein is therefore a rather weak T 2 contrast agent. Replacing its native iron core with a synthetic paramagnetic core has proven to result in effective T 2 contrast agents both in vitro 40, 41 and in vivo. 42 More sensitive detection methods using phase images for generating hyperintense (bright) contrast might improve the detection of specific FerrH contrast generation, as was proposed recently by Mills and Ahrens. 43 Our timeline data also demonstrate that contrast generation by viral vector-mediated overexpression of MR reporter genes is a dynamic process, resulting from the added effects of the vector-dependent kinetics of transgene expression, the delay between gene expression and contrast generation required to accumulate iron into iron-sequestering proteins and the possible contribution of an immune response to the vector injection, which can complicate interpretation of the data.
CONCLUSIONS
In conclusion, we have evaluated in depth the potential of ferritin as an MRI reporter gene in the mouse brain with two different viral vector systems. We have compared LVs and AAVs as these are the most promising viral vectors for applications in the CNS. We have developed a new quantification method, which has allowed us to quantify for the first time the use of the ferritin reporter in the rodent brain. We have shown that viral vector injection itself results in hypointense contrast at the site of injection in the mouse brain on T 2 *-weighted MRI. When comparing LV with AAV for MRI reporter gene expression, AAV seems the preferred vector system because of low background contrast and high transgene expression levels, although enhancement of the sensitivity and specificity of the MR reporter systems will remain a challenge in the future.
MATERIALS AND METHODS
Cell culture
293T (human embryonic kidney) and SHSY5Y (human neuroblastoma) cells were grown as a monolayer and propagated in DMEM (Dulbecco'
s medium) with Glutamax (Gibco BRL, supplied by Invitrogen, Merelbeke, Belgium), supplemented with 10% heat-inactivated fetal calf serum or 15% fetal calf serum+1% non-essential amino acids for SHSY5Y cells (Sigma-Aldrich, Bornem, Belgium) and 50 mg ml À1 gentamicin (Gibco BRL) and were cultured at 37 1C in a humidified atmosphere containing 5% CO 2 .
Trypsin was purchased from Sigma-Aldrich.
Vector constructs
The construction of pCHMWS-eGFP and pCHMWS-eGFP-T2A-fLuc lentiviral transfer plasmids has been described previously. 27 The hFerrH (human FerrH) cDNA was a kind gift from Dr P Arosio (University of Brescia, Italy). Using this plasmid as a template, the FerrH cDNA was amplified with PCR, using a sense PCR primer to introduce a XbaI restriction site upstream and an antisense primer designed to remove the STOP codon and introduce a XhoI restriction site downstream of the FerrH cDNA. From pCHMWS-eGFP-T2A-fLuc, the eGFP cDNA was cut out by restriction digest using XbaI and XhoI and replaced with the digested XbaI-FerrH-XhoI PCR product, resulting in the pCHMWSFerrH-T2A-fLuc plasmid construct. Plasmids for the AAV production were kindly provided by Dr J Wilson (University of Pennsylvania, PA, USA). The plasmids include the constructs for the AAV2/7 serotype, the AAV transfer plasmid (pZac 2.1 eGFP3 SEED) encoding the eGFP transgene under the control of the ubiquitous CMV (cytomegalovirus) promoter and finally the pAdvDeltaF6 adenoviral helper plasmid. The AAV transfer plasmid with the AAV2-inverted terminal repeats flanking the CMV promoter-eGFP-WPRE-bovine growth hormone polyadenylation sequence was modified to include both FerrH and fLuc as transgenes under control of the CMV promoter. Initially, a multiple cloning site was cloned between the NotI and BamHI sites in the original transfer plasmid to replace the eGFP transgene. Into the XbaI and MluI restriction sites of this multiple cloning site, we ligated the eGFP-T2A-fLuc and the FerrH-T2A-fLuc sequences, cut out from the pCHMWS-eGFP-T2A-fLuc and pCHMWSFerrH-T2A-fLuc plasmids by restriction with XbaI and MluI, resulting in the pAAV-TF-CMV-FerrH-T2A-fLuc plasmid construct.
Viral vector production
The production of LV was performed as described earlier 30 with minor modifications. Filtered vector particles were concentrated using Vivaspin 15 columns (Vivascience, Hannover, Germany), aliquoted and stored at À80 1C. For a protocol on the adenovirus-free rAAV (serotype 2/7) production and quality control, we refer to Supplementary Materials and Methods online.
Transduction of cells
For transduction experiments, cells were seeded in a 96-well plates at 20 000 cells per well. The next day, the cells were transduced with LV preparations (multiplicity of infection¼11.8 TU per cell) serially diluted (1/3) in DMEM supplemented with 10% fetal calf serum. After 24 h of incubation, the vectors were washed from the cells and medium was replaced. Cells were passaged (1/10) at least 4 times to exclude pseudo-transduction. Stably transduced cells were grown and used in different experimental settings.
In vitro luciferase enzyme activity assay
For measuring the luciferase activity in cells, transduced cells were washed with PBS and subsequently lysed with 40 ml of lysis buffer containing 50 mM Tris pH 7.5, 200 mM NaCl, 0.2% NP40, 1 mM PMSF (phenylmethylsulfonyl fluoride) and 10% glycerol. In all, 5 ml of this cell lysate was assayed for luciferase activity according to the manufacturer's protocol (ONE-Glo Luciferase Assay System, Promega, Madison, WI, USA), and the produced light was measured using an integration time of 5 s with a Glomax luminometer (Promega Benelux, Leiden, The Netherlands). Data were normalized to the total protein concentration, which was determined by the bicinchoninic acid assay (Pierce, Rockford, IL, USA).
Western blot analysis
Western blot analysis was performed as described before, 27 using the following primary antibodies: rabbit polyclonal human FerrH antibody (1:500, Santa Cruz Biotechnology, Heidelberg, Germany), rabbit polyclonal eGFP antibody (1:10 000, see the study by Baekelandt et al. 29 ) or goat polyclonal fLuc antibody (1:1000, Promega). To confirm equal loading of the protein samples, blots were reprobed with a mouse monoclonal primary antibody to a-tubulin (1:10 000, T5168, Sigma-Aldrich, St Louis, MI, USA). For detection and densitometry, a LAS-3000 mini Image Reader and Aida Image Analyse v4.19 software was used (Fujifilm, Düsseldorf, Germany).
Immunocytochemistry and confocal microscopy
Stably transduced 293T and SHSY5Y cells were seeded at 200 000 cells per well in a 24-well plate on fibronectin-coated coverslips. After 48 h, cells were washed twice with PBS and fixed during 15 min with 4% paraformaldehyde. For staining, cells were incubated for 5 min in 0.1% Triton X-100 in PBS, blocked during 20 min in PBS containing 1% bovine serum albumin and 10% donkey serum before incubation (2 h) with primary mouse monoclonal human FerrH antibody (rH02, 1:200 (ref. 49)) or rabbit polyclonal eGFP antibody (1:10 000, see the study by Baekelandt et al. 29 ). After washing, cells were incubated in donkey anti-mouse and donkey anti-rabbit secondary antibodies, conjugated to Alexa 555 and Alexa 488 fluorophores (1:500, Dako, Glostrup, Denmark), respectively. Coverslips were mounted in mowiol supplemented with DAPI nuclear stain. Cells were imaged by laser scanning confocal microscopy (ConfoCor2; Carl Zeiss, Oberkochen, Germany).
Iron assessment in cells
Wild-type and stably transduced FerrH-T2A-fLuc and eGFP-T2A-fLuc 293T cells were cultured in medium with and without ferric ammonium citrate (2.5 mM, Sigma-Aldrich). After 8 days, cells were trypsinized and seeded for Prussian blue staining (cfr infra) or harvested for inductively coupled plasma mass spectrometry and MRI experiments by trypsinization, followed by three washes with PBS and fixing in 4% paraformaldehyde. Samples, each containing ± 5Â10 6 cells, were prepared in triplicate and kept at À20 1C before analysis by inductively coupled plasma mass spectrometry (Elan 6000 DRC plus, Perkin-Elmer, Paris, France). In parallel, harvested 293T cells ( ± 5Â10 6 cells) were left to settle on the bottom of 0.2 ml microcentrifuge tubes and embedded in agar (1.4%, Sigma-Aldrich) for MRI studies.
Prussian blue staining on cells
Stably transduced and untransduced control 293T cells were propagated in the cell culture medium with and without Fe 3+ supplementation (ferric ammonium citrate, 2.5 mM, 8 days) and seeded at 200 000 cells per well in a 24-well plate on fibronectin-coated coverslips. The cells were left overnight to attach to the coverslips, before fixation with 4% paraformaldehyde. The cells were incubated in Prussian blue working solution, prepared by mixing equal parts of 20% aqueous hydrochloric acid and 10% potassium ferrocyanide solutions just before use, washed with distilled water, counterstained by nuclear fast red and coverslipped with mowiol. Chemicals were purchased from Sigma-Aldrich.
Stereotactic vector injection
Adult C57BL/6-Tyr cÀ2J /J and NOD-SCID mice were housed under 14 h light-10 h dark cycle with free access to food and water. All animal experiments were approved by the bioethical committee of the KU Leuven. For surgery, 8-9-week-old mice were anesthetized as described before 44 and placed in a stereotactic head frame (Stoelting, Wood Dale, IL, USA). A midline incision of the skin was made and a small hole drilled in the skull at the appropriate location, using the bregma as a reference. Mice were then stereotactically injected in the right (experimental condition) and left (control) striata with 3 ml LV (2.8Â10 5 pg p24), AAV (1.5Â10 10 genome copy), concentrated medium or PBS (depending on the experiment) using stereotactic coordinates (anteroposterior 0.5, lateral (À)2.0 and dorsoventral 3.0-2.0 mm) based on the Paxinos anatomical atlas of the mouse brain (total n¼39). The animals were kept in individually ventilated cages until killing.
In vivo BLI
Mice were anesthetized and imaged in an IVIS 100 system (Xenogen, Alameda, CA, USA). Anesthesia was induced in an induction chamber with 2% isoflurane in 100% oxygen at a flow rate of 1 l per min and maintained in the IVIS with a 2% mixture at 0.5 l per min as described before. 44 Mice were intravenously injected with D-luciferin (126 mg kg À1 , Promega Benelux) Evaluation of ferritin as MRI reporter gene G Vande Velde et al dissolved in PBS (15 mg ml À1 ). Subsequently, they were placed in the prone position in the IVIS with a field of view of 10 cm. Consecutive 1-min frames were acquired until the maximum signal was reached. For the quantification of fLuc reporter gene activity in vivo, the data are reported as the photon flux (p/s) from a 1 cm 2 circular ROI on the head of the mouse.
Magnetic resonance imaging
Magnetic resonance images were acquired using a 9.4-T Biospec small animal MRI scanner (Bruker Biospin, Ettlingen, Germany) with a horizontal bore of 11.7 cm and equipped with actively shielded gradients (600 mTm À1 ). For MRI experiments on cell suspensions, the 0.2 ml microcentrifuge tubes containing agar-embedded cells were placed in a 3.5-cm culture dish and embedded in 1.4% agar (Sigma-Aldrich). MR images were acquired using a quadrature resonator with an inner diameter of 7 cm (Bruker Biospin) or a purpose-built radio-frequency solenoid coil with an inner diameter of 4 cm (both transmitreceive). Two-dimensional multi-slice-multi-echo experiments were acquired for the calculation of T 2 maps (repetition time¼6000 ms and 16 echo time (TE) increments of 10 ms, 256Â256 matrix, 175Â175 mm 2 in plane resolution, 24 continuous slices of 0.4-mm slice thickness). T 2 * maps were acquired with identical geometric settings to multi-slice-multi-echo experiments using a gradient echo pulse sequence and 12 TE increments, first TE¼4 ms with 6 ms echo spacing. High-resolution 3D T 2 *-weighted MR images were acquired using a gradient echo sequence (fast low-angle shot, repetition time¼100 ms, TE¼12 ms, flip angle 301). The field of view was 3.8Â3.8Â1.2 cm 3 and the isotropic resolution was 132 mm.
For in vivo MRI experiments, anesthesia of mice was induced in an induction chamber with 3-4% isoflurane in 100% oxygen and maintained in the MRI scanner at 1-2% in 100% oxygen. Respiration and body temperature were monitored throughout the measurements and maintained at 37 1C and 70-120 per min, respectively. MRI experiments were performed using a 7-cm linearly polarized resonator for transmission and an actively decoupled 1-cm surface coil for receiving (both Bruker Biospin). After acquisition of twodimensional multi-slice localizer images, two-dimensional multi-slice-multiecho experiments were acquired for the calculation of T 2 maps (repetition time¼4000 ms and 16 TE increments of 10 ms, 78Â78 mm 2 in plane resolution, 24 slices of 0.4 mm thickness). T 2 * maps were acquired with identical geometric settings to multi-slice-multi-echo experiments using a gradient echo pulse sequence and 12 TE increments with TE¼4 and 6 ms echo spacing. Highresolution 3D T 2 * weighted images (fast low-angle shot, repetition time-100 ms, TE¼12 ms, flip angle 301, 59 mm isotropic resolution) were acquired before and at different time points after vector injection. After the last time point, animals were killed, perfused and ex vivo MR images of the excised, paraformaldehyde-fixed brains were acquired. Hereby, the perfused brains were submerged in perfluoropolyether (fombline, Sigma-Aldrich) to avoid background signal and geometrically fixed in a 2 ml syringe. In addition to the MRI protocol for live animals, a high-resolution 3D T 2 *-weighted fast low-angle shot with an isotropic resolution of 32 mm (8 averages) was acquired using the same acquisition and geometric parameters (including the field of view) as for the 3D T 2 *-weighted images with the lower resolution.
MRI data analysis
Images were processed using Paravision 4 and 5 (Bruker Biospin). Relaxation times (T 2 /T 2 *) were determined as mean values of selected ROIs, which were selected on homogeneous sections of the cell-loaded areas in the agar phantoms or from manually defined areas around the injection site for in vivo images. Owing to the influence of agar concentrations in cell phantoms, T 2 /T 2 * values are stated relative to unlabeled control cells in the same phantom. Used areas include those around the needle tract (also see below), areas corresponding to histologically confirmed regions of cell transduction (Supplementary Figure S2) and areas around (of B1 mm thickness) but excluding the hypointense needle tract. Values were typically compared with those of wild-type cells without iron supplementation for phantom experiments and identical regions from the contralateral hemisphere for in vivo MR images. Data were expressed as mean ± s.d. Significance tests were performed using ANOVA (analysis of variance) (Microsoft Office Excel 2007, Microsoft Corporation, Seattle, WA, USA) with P-values of o0.05 considered significant, and data were represented using GraphPad Prism 5 (GraphPad Software, La Jolla, CA, USA).
The multi-temporal 3D fast low-angle shot MRI images were quantitatively analyzed using an in-house developed (semi-)automated image analysis pipeline described in the study by Rangarajan et al. 45 written in MATLAB (Mathworks, Natick, MA, USA) (Supplementary Figure S1) . The images were corrected first for MRI intensity inhomogeneity using the method described in the study by Likar et al. 46 Images from different time points were spatially aligned by affine image registration using the method of Maes et al. 47 Baseline images acquired before injection were spatially aligned to an MR template image in the Paxinos atlas reference frame 48 using the same registration approach. Two VOIs encompassing the left and right sites of injection were defined in the atlas template based on the coordinates used for stereotactic surgery (stereotactic vector injection), as well as a third region (the periaqueductal gray), which was used as a reference region for intensity normalization. The VOIs and the reference region were automatically located in each of the individual images using the spatial transformations obtained by registration. Inter-temporal and inter-animal variation in MRI intensity was accounted for by normalizing the intensities within each VOI to the mean ( 
Histology
To assess vector transduction histologically, mice were deeply anesthetized with pentobarbital (Nembutal, CEVA Santé Animale, Libourne, France) and perfused transcardially with saline, followed by ice-cold 4% paraformaldehyde in PBS. The brain was removed from the skull and post-fixed overnight in the same fixing solution. Coronal brain sections (50 mm thick) were cut suing a vibratome and stored at 4 1C in PBS buffer containing 0.1% sodium azide. For immunohistochemistry, the following primary antibodies were used: polyclonal rabbit anti-eGFP (1:10 000, see the study by Baekelandt et al. 29 ), primary mouse monoclonal anti-human FerrH antibody (1:200, rH02, see the study by Cozzi et al. 49 ). To detect macrophages, we used a monoclonal antibody against mouse CD11b (Serotec, Oxford, UK). T lymphocytes were stained with monoclonal antibodies against mouse CD4 and CD8 (BD Pharmingen, San Diego, CA, USA). After a treatment with 3% H 2 O 2 , floating sections were incubated overnight with the primary antibody in 10% serum and 0.1% Triton X-100. The sections were then incubated with the appropriate biotinylated secondary antibody (diluted 1:300, Dako), followed by an incubation with the streptavidin-horseradish peroxide complex (1:1000, Dako). Detection was performed with DAB, using H 2 O 2 as a substrate. For histochemical staining (DAB-enhanced Prussian blue, cresyl violet, hematoxylin-eosin), the sections were mounted on glass slides before applying the specific staining procedure using standard protocols.
